Welcome to the online edition of the Journal of Psychiatry and Neuroscience, the official journal of the Canadian College of Neuropsychopharmacology.
Psychopharmacology for the Clinician
Metformin for antipsychotic-induced metabolic disturbances
Latest Articles
-
Increasing catecholamine release through the administration of dexamphetamine (0.45 mg/kg) increases temporal and spatial binding windows in the unimodal funnelling illusion.
-
Metformin is safe and effective for reducing antipsychotic-induced weight gain in individuals with intellectual and developmental disabilities.
-
Dopaminergic mistargeting may account, in part, for the presence of positive symptoms, and a reduction in terminals from intended targets may explain some of the negative symptoms and cognitive deficits observed in individuals with psychiatric disorders.
-
Active inference modelling of a probabilistic task may provide further explanation for dysfunctional mechanisms underlying decision-making in psychosis.
-
Thalamocortical functional connectivity, based on the intrinsic network architecture of the brain, appears to be clinically relevant in ADHD.
